Article info
PDFReview
Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland
- Correspondence to Dr Christophe Le Tourneau, Département d'Oncologie Médicale – Unité d'Investigation Clinique, Institut Curie, 26, rue d'Ulm – 75248 Paris Cedex 05; christophe.letourneau{at}curie.net
Citation
Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland
Publication history
- Accepted December 4, 2010
- First published December 22, 2010.
Online issue publication
December 13, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.